Investors

News Release Details

Opiant Pharmaceuticals to Report First Quarter 2019 Financial Results and Host Conference Call and Webcast on Thursday, May 9

April 30, 2019 at 4:05 PM EDT

SANTA MONICA, Calif., April 30, 2019 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. ("Opiant") (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today announced that it will report its financial results for the first quarter ended March 31, 2019, after the market close, and will host a corporate update conference call and webcast on Thursday, May 9, at 4:30 p.m. Eastern Time.

                   
Conference Call Details
Thursday, May 9th  @ 4:30pm Eastern Time/1:30pm Pacific Time
Toll Free:                 877-407-0792
International:                 201-689-8263
Conference ID:                 13689678
Webcast:                 http://public.viavid.com/index.php?id=134030
                   

About Opiant Pharmaceuticals, Inc.
Opiant Pharmaceuticals, Inc. is a specialty pharmaceutical company developing medicines for addictions and drug overdose. The National Institute on Drug Abuse, a division of NIH, describes addictive disorders as chronic relapsing brain diseases that burden society at both the individual and community levels. Opiant's first drug overdose product, NARCAN® Nasal Spray, is licensed to Adapt Pharmaceuticals, now owned by Emergent BioSolutions, Inc. For more information, visit www.opiant.com.

CONTACTS:
For Media Inquiries:
Julie Normart, W2O Group
(415) 946-1087
jnormart@w2ogroup.com

For Investor Inquiries:
Dan Ferry, LifeSci Advisors, LLC
(617) 535-7746
Daniel@lifesciadvisors.com

Opiant logo.jpg

Source: Opiant Pharmaceuticals, Inc.